Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Allen

Showing results (341-350 of 381) with videos related to

Pageof 39
Sort By:
Journal of Medical Imaging (Bellingham, Wash.)|July 3, 2020
Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasmsKate A Harrington, Travis L Williams, Sharon A Lawrence, et al.
Annals of Surgery|June 6, 2014
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinomaEileen M OʼReilly, Anna Perelshteyn, William R Jarnagin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2016
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres AloneKaren T Brown, Richard K Do, Mithat Gonen, et al.
Annals of Surgery|December 6, 2019
Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional StudyAlessandra Pulvirenti, Georgios A Margonis, Vicente Morales-Oyarvide, et al.
Cancer|June 24, 2020
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinomaCaitlin A McIntyre, Sharon A Lawrence, Allison L Richards, et al.
Annals of Surgery|January 13, 2017
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery ConsortiumMarc A Attiyeh, Carlos Fernández-Del Castillo, Mohammad Al Efishat, et al.
Annals of Surgical Oncology|November 22, 2024
Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell CarcinomaAlex B Blair, Shannon N Radomski, Joanne Chou, et al.
Annals of Surgical Oncology|July 1, 2015
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding MetastasesJimme K Wiggers, Bas Groot Koerkamp, Robert J Coelen, et al.
JCO Precision Oncology|February 23, 2024
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic CholangiocarcinomaSarah M McIntyre, William A Preston, Henry Walch, et al.
Endoscopy|September 19, 2015
Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainageJimme K Wiggers, Bas Groot Koerkamp, Robert J Coelen, et al.
Pageof 39

Showing results (341-350 of 381) with videos related to

Sort By:
Pageof 39
Journal of Medical Imaging (Bellingham, Wash.)|July 3, 2020
Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasmsKate A Harrington, Travis L Williams, Sharon A Lawrence, et al.
Annals of Surgery|June 6, 2014
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinomaEileen M OʼReilly, Anna Perelshteyn, William R Jarnagin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2016
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres AloneKaren T Brown, Richard K Do, Mithat Gonen, et al.
Annals of Surgery|December 6, 2019
Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional StudyAlessandra Pulvirenti, Georgios A Margonis, Vicente Morales-Oyarvide, et al.
Cancer|June 24, 2020
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinomaCaitlin A McIntyre, Sharon A Lawrence, Allison L Richards, et al.
Annals of Surgery|January 13, 2017
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery ConsortiumMarc A Attiyeh, Carlos Fernández-Del Castillo, Mohammad Al Efishat, et al.
Annals of Surgical Oncology|November 22, 2024
Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell CarcinomaAlex B Blair, Shannon N Radomski, Joanne Chou, et al.
Annals of Surgical Oncology|July 1, 2015
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding MetastasesJimme K Wiggers, Bas Groot Koerkamp, Robert J Coelen, et al.
JCO Precision Oncology|February 23, 2024
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic CholangiocarcinomaSarah M McIntyre, William A Preston, Henry Walch, et al.
Endoscopy|September 19, 2015
Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainageJimme K Wiggers, Bas Groot Koerkamp, Robert J Coelen, et al.
Pageof 39